Wells Fargo’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-250
| Closed | – | – | 6312 |
|
|
2018
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 6293 |
|
|
2018
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 6318 |
|
|
2018
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 6235 |
|
|
2017
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 6242 |
|
|
2017
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 6234 |
|
|
2017
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 6234 |
|
|
2017
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 6230 |
|
|
2016
Q4 | $0 | Buy |
250
+125
| +100% | – | ﹤0.01% | 6256 |
|
|
2016
Q3 | $1K | Sell |
125
-375
| -75% | -$3K | ﹤0.01% | 5782 |
|
|
2016
Q2 | $5K | Buy |
500
+250
| +100% | +$2.5K | ﹤0.01% | 5528 |
|
|
2016
Q1 | $3K | Buy |
+250
| New | +$3K | ﹤0.01% | 5734 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$4K | – | 6455 |
|
|
2014
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 5699 |
|
|
2014
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 5671 |
|
|
2014
Q1 | $5K | Sell |
100
-63
| -39% | -$3.15K | ﹤0.01% | 5397 |
|
|
2013
Q4 | $6K | Buy |
163
+113
| +226% | +$4.16K | ﹤0.01% | 5192 |
|
|
2013
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 5187 |
|
|
2013
Q2 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 5153 |
|